[HTML][HTML] The evolving landscape of PD-1/PD-L1 pathway in head and neck cancer
X Qiao, J Jiang, X Pang, M Huang, Y Tang… - Frontiers in …, 2020 - frontiersin.org
Over the past 10 years, cancer immunotherapy has made significant progress in multiple
cancer types and has been gradually been applied to clinical cancer care, in which the …
cancer types and has been gradually been applied to clinical cancer care, in which the …
[HTML][HTML] Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies
M Hojjat-Farsangi - International journal of molecular sciences, 2014 - mdpi.com
Chemotherapeutic and cytotoxic drugs are widely used in the treatment of cancer. In spite of
the improvements in the life quality of patients, their effectiveness is compromised by several …
the improvements in the life quality of patients, their effectiveness is compromised by several …
ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors
R Roskoski Jr - Pharmacological research, 2014 - Elsevier
The epidermal growth factor receptor (EGFR) family consists of four members that belong to
the ErbB lineage of proteins (ErbB1–4). These receptors consist of an extracellular domain …
the ErbB lineage of proteins (ErbB1–4). These receptors consist of an extracellular domain …
[HTML][HTML] The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact
Squamous-cell cancer of the head and neck (SCCHN) represents a heterogeneous disease
entity, with various etiological factors implicated in the genesis of distinct molecular subsets …
entity, with various etiological factors implicated in the genesis of distinct molecular subsets …
EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
JJ Kang, A Ko, SH Kil, JMS Clair, DS Shin… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Receptor tyrosine kinases (RTKs) are cell surface receptors that bind growth factor ligands
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …
[HTML][HTML] Anti-EGFR therapies in nasopharyngeal carcinoma
X Chen, R Liang, X Zhu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Nasopharyngeal carcinoma (NPC) is a common malignant tumor in Southern China and
South-East Asia. Regardless of initiative high response to radiotherapy, parts of patients still …
South-East Asia. Regardless of initiative high response to radiotherapy, parts of patients still …
[HTML][HTML] EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect
Q Xu, Q Zhang, Y Ishida, S Hajjar, X Tang, H Shi… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract “Warburg effect”, the enhanced glycolysis or aerobic glycolysis, confers cancer cells
the ability to survive and proliferate even under stressed conditions. In this study, we …
the ability to survive and proliferate even under stressed conditions. In this study, we …
Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review
A Guidi, C Codecà, D Ferrari - Medical Oncology, 2018 - Springer
Head and neck cancer (HNC) is a fatal malignancy with an overall long-term survival of
about 50% for all stages. The diagnosis is not rarely delayed, and the majority of patients …
about 50% for all stages. The diagnosis is not rarely delayed, and the majority of patients …
Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics
UU Malik, S Zarina, SR Pennington - Archives of oral biology, 2016 - Elsevier
Background The molecular and cellular mechanisms underlying the pathogenesis of oral
squamous cell carcinoma (OSCC) are relatively poorly understood and remain a subject of …
squamous cell carcinoma (OSCC) are relatively poorly understood and remain a subject of …
Combination antiangiogenic therapy and radiation in head and neck cancers
Tumor angiogenesis is a hallmark of advanced cancers and promotes invasion and
metastasis. Over 90% of head and neck squamous cell carcinomas (HNSCC) express …
metastasis. Over 90% of head and neck squamous cell carcinomas (HNSCC) express …